Summary The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV) infections by 2030. However, the HBV prevalence in Western countries, where the historical prevalence is low and highly impacted by immigration trends, remains uncertain making planning difficult. We aimed to develop a more accurate estimate of HBV prevalence and identify key […]
Резюме Хроническая инфекция вирусами гепатита B и C (HBV и HCV) является одним из основных факторов заболеваний печени и смертности, связанной с печенью, в Узбекистане. Необходимо продемонстрировать осуществимость крупномасштабного упрощенного тестирования и лечения для внедрения национальной программы ликвидации вирусного гепатита. Тринадцать поликлиник были задействованы для скрининга, проведения последующих биохимических […]
Summary Background Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given current trends. Methods This analysis […]
Summary Background Treatment for infection with hepatitis C virus (HCV) during pregnancy has not yet been approved; however, interventions specifically targeting women, especially those of childbearing age (15–49 years), could prevent vertical transmission and community spread. To assess the impact of such interventions, improved prevalence estimates in this group are needed. We aimed to estimate […]
Russian 
English 
Spanish 
French 
Arabic